Cell line name |
TU-1 |
Accession |
CVCL_M530 |
Resource Identification Initiative |
To cite this cell line use: TU-1 (RRID:CVCL_M530) |
Comments |
Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Cell type: Plasma cell; CL=CL_0000786. |
Sequence variations |
|
Disease |
Plasma cell myeloma (NCIt: C3242) Multiple myeloma (ORDO: Orphanet_29073) |
Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
Sex of cell |
Male |
Age at sampling |
59Y |
Category |
Cancer cell line |
Publications | CLPUB00455 Kari Koskela, Tarja-Terttu Pelliniemi, Kari Remes, Rocco Savino, Gennaro Ciliberto, Kari Pulkki; Establishment of three new myeloma cell lines from bone marrow plasma cells: response to interleukin-6 and interleukin-6-antagonist. (In conference) Proceedings of the Vth international workshop on multiple myeloma; pp.3.83-3.83; International Myeloma Foundation; La Baule; France (1995) PubMed=9249875; DOI=10.3109/00365519709099401 Hanna Ollikainen, Stina M. Syrjanen, Kari Koskela, Tarja-Terttu Pelliniemi, Kari Pulkki; p53 gene mutations are rare in patients but common in patient-originating cell lines in multiple myeloma. Scand. J. Clin. Lab. Invest. 57:281-289(1997) PubMed=10936422; DOI=10.1016/S0145-2126(99)00195-2 Hans Gunther Drexler, Yoshinobu Matsuo; Malignant hematopoietic cell lines: in vitro models for the study of multiple myeloma and plasma cell leukemia. Leuk. Res. 24:681-703(2000) PubMed=11818668; DOI=10.1159/000046625 Kari Koskela, Tarja-Terttu Pelliniemi, Lauri J. Pelliniemi, Kari Remes, Karl-Ove Soderstrom, Kari Punnonen, Rajiv Kumar, Hanna Ollikainen, Kari Pulkki; Autocrine production and synergistic growth-promoting activity of interleukin-6 and oncostatin M in a new human myeloma cell line TU-1. Acta Haematol. 107:23-28(2002) |
Cross-references |
Cell line databases/resources |
cancercelllines; CVCL_M530
|
Encyclopedic resources |
Wikidata; Q54973321
|
Entry history |
Entry creation | 05-Nov-2013 |
Last entry update | 14-Aug-2025 |
Version number | 16 |
---|